| abstract |
FIELD: biochemistry.SUBSTANCE: invention relates to the single-domain Ebola VP24 antibody capable of specifically binding to the Ebola VP24 antigen, as well as to use thereof for treating Ebola disease, for preventing the development of Ebola disease, as well as to use thereof for preventing the recurrence of Ebola disease. Also disclosed is an isolated polypeptide capable of specifically binding to Ebola VP24 antigen.EFFECT: invention enables effective treatment of Ebola's disease.20 cl, 4 ex, 4 tbl, 10 dwg |